G. Weiland

发表

Effects of magnesium and N-ethylmaleimide on the binding of 3H-hydroxybenzylisoproterenol to beta-adrenergic receptors.

P. Molinoff, K. Heidenreich, G. Weiland, 1982, The Journal of biological chemistry.

Pharmacological characterization of two calcium currents in GH3 cells.

R. Oswald, S. Simasko, G. Weiland, 1988, The American journal of physiology.

Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes.

P. Molinoff, B. Wolfe, G. Weiland, 1981, Life sciences.

Rapid incorporation of the solubilized dihydropyridine receptor into phospholipid vesicles.

R. Oswald, R. Cerione, W. Horne, 1986, Biochimica et biophysica acta.

Structure-activity relationship for substance P inhibition of carbamylcholine-stimulated 22Na+ flux in neuronal (PC12) and non-neuronal (BC3H1) cell lines.

S. Simasko, G. Weiland, J. Soares, 1985, The Journal of pharmacology and experimental therapeutics.

Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.

M. Donowitz, G. Sharp, F. Homaidan, 1989, The American journal of physiology.

Substance P inhibits carbamylcholine-stimulated 22Na+ efflux from acetylcholine receptor-enriched Torpedo electroplaque membrane vesicles

C. Min, G. Weiland, 1992, Brain Research.

Characterization of radiolabeled agonist binding to beta-adrenergic receptors in mammalian tissues.

P. Molinoff, K. Heidenreich, G. Weiland, 1980, Journal of cyclic nucleotide research.

Ligand specificity of state transitions in the cholinergic receptor: behavior of agonists and antagonists.

G. Weiland, P. Taylor, 1979, Molecular pharmacology.

Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.

P. Molinoff, K. Minneman, G. Weiland, 1980, Molecular pharmacology.

Specific activation of the alpha 7 nicotinic acetylcholine receptor by a quaternary analog of cocaine.

R E Oswald, R. Oswald, M. Francis, 2001, Molecular pharmacology.

Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.

P. Molinoff, G A Weiland, P B Molinoff, 1981, Life sciences.

Effect of neurotensin, substance P and TRH on the regulation of dopamine receptors in rat brain.

S. Simasko, G. Weiland, 1984, European journal of pharmacology.

The mechanism of binding of dihydropyridine calcium channel blockers to rat brain membranes.

R. Oswald, G. Weiland, 1985, The Journal of biological chemistry.

Fundamental difference between the molecular interactions of agonists and antagonists with the β-adrenergic receptor

P. Molinoff, K. Minneman, Perry B. Molinoff, 1979, Nature.

Stimulation of insulin secretion by denatonium, one of the most bitter-tasting substances known.

G. Sharp, S. G. Straub, G. Weiland, 2003, Diabetes.

Two components of carbamylcholine-induced loss of nicotinic acetylcholine receptor function in the neuronal cell line PC12.

S. Simasko, G. Weiland, J. Soares, 1986, Molecular pharmacology.

Affinity labeling of the subunits of the membrane associated cholinergic receptor.

G. Weiland, P. Taylor, D. Frisman, 1979, Molecular pharmacology.

The loss of an electrostatic contact unique to AMPA receptor ligand binding domain 2 slows channel activation.

L. Nowak, R. Oswald, S. Holley, 2012, Biochemistry.

Solubilization and hydrodynamic characterization of the dihydropyridine receptor from rat ventricular muscle.

R. Oswald, W. Horne, G. Weiland, 1986, The Journal of biological chemistry.

[3H]Batrachotoxinin A-20-α-benzoate Binding in Synaptosomes from Susceptible and kdr-Type Resistant German Cockroaches, Blattella germanica (L.)

K. Dong, G. Weiland, J. G. Scott, 1993 .

Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.

G. Yaney, G. Sharp, G. Weiland, 1991, The Journal of pharmacology and experimental therapeutics.

A comparison of the beta-adrenergic receptor of the turkey erythrocyte with mammalian beta1 and beta2 receptors.

P. Molinoff, K. Minneman, G. Weiland, 1980, Molecular pharmacology.

Two domains of the beta subunit of neuronal nicotinic acetylcholine receptors contribute to the affinity of substance P.

R. Oswald, B. Cohen, A. Figl, 1998, The Journal of pharmacology and experimental therapeutics.

Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.

J. A. Durkin, J. Henley, S. Simasko, 1987, Molecular pharmacology.

Kinetics of agonist-mediated transitions in state of the cholinergic receptor.

C. Chignell, G. Weiland, P. Taylor, 1977, The Journal of biological chemistry.

Inhibition of hormone-stimulated adenylate cyclase activity after altering turkey erythrocyte phospholipid composition with a nonspecific lipid transfer protein. Phosphatidylinositol uncouples catecholamine binding from adenylate cyclase activation.

D. B. Zilversmit, G. Weiland, C. C. McOsker, 1983, The Journal of biological chemistry.

Ligand interactions with cholinergic receptor-enriched membranes from Torpedo: influence of agonist exposure on receptor properties.

C. Chignell, V. Wee, G. Weiland, 1976, Molecular pharmacology.

Functional reconstitution of skeletal muscle Ca2+ channels: separation of regulatory and channel components.

R. Oswald, R. Cerione, E. Racker, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Effects of Substance P on the Binding of Agonists to the Nicotinic Acetylcholine Receptor of Torpedo Electroplaque

C. Min, G. Weiland, 1993, Journal of neurochemistry.

Dynamics of Cleft Closure of the GluA2 Ligand-binding Domain in the Presence of Full and Partial Agonists Revealed by Hydrogen-Deuterium Exchange*

C. Ptak, C. Hsieh, R. Oswald, 2013, The Journal of Biological Chemistry.

Role of Stoichiometry in the Dimer-Stabilizing Effect of AMPA Receptor Allosteric Modulators

Ching-Lin Hsieh, C. Ptak, C. Hsieh, 2013, ACS chemical biology.

The beta subunit of neuronal nicotinic acetylcholine receptors is a determinant of the affinity for substance P inhibition.

R. Oswald, G. Weiland, G. A. Stafford, 1994, Molecular pharmacology.

Effects of Substance P on Nicotinic Acetylcholine Receptor Function in PC 12 Cells

S. Simasko, G. Weiland, Steven M. Simasko, 1987, Journal of neurochemistry.